KYMR
Kymera Therapeutics Inc.
$59.91
+$2.70(+4.72%)
66
Overall
60
Value
75
Tech
63
Quality
Market Cap
$4.07B
Volume
583.17K
52W Range
$19.45 - $59.00
Target Price
$64.33
EPS Estimates Overview
| Current Quarter | $-0.72 | Next Quarter | $-0.85 |
| Current Year | $-3.29 | Next Year | $-3.94 |
| QoQ Growth | -18.1% | YoY Growth | -19.8% |
| 3Y EPS CAGR | -12.6% | Target Price | $64.33 |
| Consensus | Buy | Upside | +7.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $59.91 | +4.7% | 583.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW